Content Details
Report to Congress: Medicaid Services Investment and Accountability Act of 2019 Preventing the Misclassification of Drugs Under the Medicaid Drug Rebate Program Federal Fiscal Year 2024
Loading...
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Centers for Medicare and Medicaid Services, Health and Human Services Department. "Report to Congress: Medicaid Services Investment and Accountability Act of 2019 Preventing the Misclassification of Drugs Under the Medicaid Drug Rebate Program Federal Fiscal Year 2024". Government. Health and Human Services Department, Centers for Medicare and Medicaid Services, August 21, 2025. https://www.govinfo.gov/app/details/CMR-HE22-00197297
Centers for Medicare and Medicaid Services, Health and Human Services Department. (2025, August 21). Report to Congress: Medicaid Services Investment and Accountability Act of 2019 Preventing the Misclassification of Drugs Under the Medicaid Drug Rebate Program Federal Fiscal Year 2024. [Government]. Health and Human Services Department, Centers for Medicare and Medicaid Services. https://www.govinfo.gov/app/details/CMR-HE22-00197297
Centers for Medicare and Medicaid Services, Health and Human Services Department. Report to Congress: Medicaid Services Investment and Accountability Act of 2019 Preventing the Misclassification of Drugs Under the Medicaid Drug Rebate Program Federal Fiscal Year 2024. Health and Human Services Department, Centers for Medicare and Medicaid Services, (21 Aug 2025), https://www.govinfo.gov/app/details/CMR-HE22-00197297
Centers for Medicare and Medicaid Services, Health and Human Services Department, Report to Congress: Medicaid Services Investment and Accountability Act of 2019 Preventing the Misclassification of Drugs Under the Medicaid Drug Rebate Program Federal Fiscal Year 2024, GovInfo, (August 21, 2025), https://www.govinfo.gov/app/details/CMR-HE22-00197297